BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3163867)

  • 1. [Scleromyxedema therapy with isotretinoin].
    Lominska-Lasota K; Rosen-Uzelac G; Reichl W; Bauer R
    Z Hautkr; 1988 Feb; 63(2):137-8, 141. PubMed ID: 3163867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.
    Sansbury JC; Cocuroccia B; Jorizzo JL; Gubinelli E; Gisondi P; Girolomoni G
    J Am Acad Dermatol; 2004 Jul; 51(1):126-31. PubMed ID: 15243538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleromyxedema: An experience using treatment with systemic corticosteroid and review of the published work.
    Lin YC; Wang HC; Shen JL
    J Dermatol; 2006 Mar; 33(3):207-10. PubMed ID: 16620228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arndt-Gottron scleromyxedema. Case report and review of therapeutic possibilities].
    Schirren CG; Betke M; Eckert F; Przybilla B
    Hautarzt; 1992 Mar; 43(3):152-7. PubMed ID: 1577603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral treatment of rosacea with 13-cis-retinoic acid].
    Nikolowski J; Plewig G
    Hautarzt; 1981 Nov; 32(11):575-84. PubMed ID: 6458582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lichen myxedematosus and scleromyxedema].
    Hödl S
    Hautarzt; 1982 Jul; 33(7):359-65. PubMed ID: 7107280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of scleromyxedema with topical betamethasone and dimethyl sulfoxide: a 30-month follow-up.
    Bonnetblanc JM; Bedane C
    Arch Dermatol; 1991 Nov; 127(11):1733-4. PubMed ID: 1952989
    [No Abstract]   [Full Text] [Related]  

  • 8. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis.
    Jablonska S; Blaszczyk M
    Eur J Dermatol; 1999; 9(7):551-4. PubMed ID: 10523735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of scleromyxedema associated with isotretinoin therapy.
    Hisler BM; Savoy LB; Hashimoto K
    J Am Acad Dermatol; 1991 May; 24(5 Pt 2):854-7. PubMed ID: 2050852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Initial scleromyxedema. Successful treatment with melphalan].
    Schubert K; Stein A; Meurer M
    Hautarzt; 2002 Jul; 53(7):478-82. PubMed ID: 12219271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cutaneous sarcoidosis with isotretinoin.
    Waldinger TP; Ellis CN; Quint K; Voorhees JJ
    Arch Dermatol; 1983 Dec; 119(12):1003-5. PubMed ID: 6580843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Scleromyxedema: immunosuppressive therapy with cyclophosphamide].
    Aberer W; Wolff K
    Hautarzt; 1988 May; 39(5):277-80. PubMed ID: 3403262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleromyxedema: possible association with seminoma.
    Alfadley A; Al Hoqail I; Al Eisa A
    J Am Acad Dermatol; 2000 May; 42(5 Pt 2):875-8. PubMed ID: 10767692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of skin appearance in a patient with scleromyxoedema after intensive chemotherapy for Hodgkin's disease.
    Alberts AS; Schulz EJ; Falkson G; Simson IW; Coccia-Portugal MA
    Dermatologica; 1989; 178(4):221-4. PubMed ID: 2767291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus].
    D'Incan M; Franck F; Kanold J; Bacin F; Achin R; Beyvin AJ; Demeocq F; Souteyrand P
    Ann Dermatol Venereol; 2001 Jan; 128(1):38-41. PubMed ID: 11226899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extracorporeal photopheresis--treatment option in scleromyxedema?].
    Durani BK; Bock M; Näher H
    Hautarzt; 2001 Oct; 52(10 Pt 2):938-41. PubMed ID: 11715388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne.
    Laquieze S; Czernielewski J; Rueda MJ
    J Drugs Dermatol; 2006; 5(10):985-90. PubMed ID: 17373148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized papular and sclerodermoid eruption: scleromyxedema.
    Serdar ZA; Altunay IK; Yasar SP; Erfan GT; Gunes P
    Indian J Dermatol Venereol Leprol; 2010; 76(5):592. PubMed ID: 20827020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleromyxedema-like fibromucinosis in a patient undergoing hemodialysis.
    McNeill AM; Barr RJ
    Int J Dermatol; 2002 Jun; 41(6):364-7. PubMed ID: 12100695
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins.
    Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.